BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	164,626.29 351.26M	-0.98% -1632.25
ALLSHR	98,999.23 613.73M	-0.76% -757.44
KSE30	50,342.54 122.55M	-1.13% -575.33
KMI30	229,014.43 138.56M	-1.61% -3757.33
KMIALLSHR	63,057.91 362.66M	-1.13% -722.77
BKTi	49,028.54 65.39M	-0.01% -2.61
OGTi	32,109.94 7.71M	-1.79% -583.79

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	66,185.00	67,760.00 64,325.00	-1640.00 -2.42%
BRENT CRUDE	71.88	71.96 70.69	0.12 0.17%
RICHARDS BAY COAL MONTHLY	96.00	0.00 0.00	-3.50 -3.52%
ROTTERDAM COAL MONTHLY	107.95	107.95 107.95	0.30 0.28%
USD RBD PALM OLEIN	1,071.50	1,071.50 1,071.50	0.00 0.00%
CRUDE OIL - WTI	66.60	66.67 65.38	0.12 0.18%
SUGAR #11 WORLD	14.05	14.10 13.78	0.18 1.30%